. Author manuscript; available in PMC: 2020 Aug 1.

Published in final edited form as: Drug Deliv Transl Res. 2019 Aug;9(4):802–815. doi: 10.1007/s13346-019-00630-5

Table 1.

PNDJ polymers used for in vitro and in vivo studies. Polymer composition was determined by ¹H NMR and JAAm content is denoted by numerical subscript in the polymer name. The weight average (M_w) and number average (M_n) molecular weights were determined by size exclusion chromatography

		Composition (mol%)		Molecular weight (g/mol)
Study	Polymer	JAAm	DBLA	M_w	M_n
In Vitro Release	PNDJ_1.02	1.02%	6.78%	35,870	19,330
	PNDJ_1.19	1.19%	7.02%	39,450	23,850
	PNDJ_1.30	1.30%	7.40%	34,040	19,810
	PNDJ_1.45	1.45%	5.48%	36,320	17,400
In Vivo Delivery Study 1	PNDJ_1.09	1.09%	6.62%	35,110	16,290
	PNDJ_1.36	1.36%	6.69%	34,040	19,810
In Vivo Delivery Study 2	PNDJ_1.02	1.02%	6.78%	35,870	19,330
	PNDJ_1.13	1.13%	6.42%	39,450	23,850
	PNDJ_1.31	1.31%	7.40%	36,870	23,150
	PNDJ_1.50	1.50%	6.63%	36,320	17,400